Science4Data Article Insights

https://www.politico.com/news/2021/03/22/astrazeneca-covid-vaccine-477526

New PR blunder undercuts AstraZeneca efforts to rebuild confidence in vaccine

2021-03-22 00:00:00, Erin Banco, POLITICO

Content Categorization
/Health/Health Conditions/Infectious Diseases
/Health/Public Health
/Health/Medical Facilities & Services/Medical Procedures
/Law & Government/Public Safety
/Business & Industrial

Word Count:
1813

Words/Sentence:
30

Reading Time:
18.13 min

Reading Quality:
Advanced

Readability:
16th or higher

Media Sentiment
Proprietary sentiment analysis on both the headline and body text of the article. Sentiment scores range from -1 (very negative sentiment) to 1 (very positive sentiment).
RCS Analysis
Relative scoring for Risk, Crisis, and Security language within the article.
Risk Score
Scoring based on the composite risk, security and crisis language within an article compared to a baseline of historic analysis across thousands of diverse articles.
PESTEL Scope
Analysis of article orientation across the PESTEL macro-environmental analysis framework. Learn more about PESTEL.
Entity Word Cloud
Key people, places, organizations and events referenced in the article, weighted by frequency and colored based on contextual sentiment.
Auto Summary
Condensing key features of the article based on salience analysis. Helpful for “gisting” the article in a time crunch.

Those include 13 European countries pulling back recommendations to use the vaccine amid reports of blood clots that so far have not been linked to the shot; all have reinstated use of the vaccine after reassurances last week from the bloc's medicines agency.

Confusion and anger around AstraZeneca's botched global rollout have frustrated government officials and vaccine experts alike, across the globe, casting a shadow over the shot that could still play a massive role in worldwide immunization efforts.

American officials and health experts are increasingly worried that AstraZeneca's shot, once billed as the world's coronavirus vaccine for its low price and ease of storage, could be dragged down by anti-vaccine rhetoric already trained on Covid-19 shots because of the record pace of their development.

There are also early data from a South African trial suggesting the vaccine is not effective against a dominant strain there, B.1.351, which has led that country to continue its suspension of the shot.

"And now you have the impression by some that the Biden administration is just dumping its doses.

All countries in the COVAX group are going ahead with it, said Bruce Aylward, a senior WHO adviser who is working with the program.

Thailand and Indonesia resumed vaccination after a brief suspension, with the Thai prime minister receiving it last week to instill confidence.

Keywords

Interested in Learning More?

Article Analysis is at the foundation of powerful media monitoring and insights. Learn what you can build with powerful curated search engines, real-time listening and trend analysis on the topics, markets and companies critical to your organization.